➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Baxter
Moodys
Dow
Johnson and Johnson

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

Details for Patent: 5,993,830


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,993,830
Title: Cosmetic skin preparation
Abstract:The present invention relates to a skin preparation comprising lipophilic and hydrophilic components, which is intended for application on skin. The skin preparation according to the present invention is characterized in that it exists as a two-phase system and it is capable of creating a semi-permeable membrane in the skin. The invention also relates to a process for the manufacture of the skin preparation as defined above, which is characterized in that the lipophilic components are dissolved in water in a separate container to be combined with hydrophilic components, which have been blended and brought to react in another vessel. Finally, the present invention also relates to different uses of the skin preparation as defined above.
Inventor(s): Freij; Goran (Stockholm, SE)
Assignee: Ponsus AB (Stockholm, SE)
Application Number:09/008,632
Patent Claim Types:
see list of patent claims
Compound; Formulation; Process; Use;

Drugs Protected by US Patent 5,993,830

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,993,830

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9700129Jan 17, 1997

International Family Members for US Patent 5,993,830

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 283684 ⤷  Free Forever Trial
Australia 5786198 ⤷  Free Forever Trial
Australia 744980 ⤷  Free Forever Trial
Brazil 9806774 ⤷  Free Forever Trial
Canada 2278521 ⤷  Free Forever Trial
China 1243431 ⤷  Free Forever Trial
Germany 69827929 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Medtronic
Harvard Business School
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.